Exagen (XGN) Cash from Operations (2018 - 2026)

Exagen (XGN) has reported Cash from Operations for 9 consecutive years, with 10417000.0 the latest figure, recorded in Q1 2026.

• Cash from Operations for Q1 2026 came in at 10417000.0, up 2.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 13371000.0 (up 10.32% YoY), and the FY2025 annual result was 13625000.0, down 2.61% from the prior year.
• Cash from Operations was 10417000.0 for Q1 2026 at Exagen, down from 3013000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 8349000.0 in Q4 2023 and troughed at 11154000.0 in Q2 2022.
• Average Cash from Operations over 5 years is 4936882.35, with a median of 5734000.0 recorded in 2022.
• Year-over-year, Cash from Operations surged 245.61% in 2023 and sank 930.03% in 2025.
• Over 5 years, Cash from Operations stood at 5734000.0 in 2022, then soared by 245.61% to 8349000.0 in 2023, then plunged by 95.65% to 363000.0 in 2024, then tumbled by 930.03% to 3013000.0 in 2025, then tumbled by 245.74% to 10417000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 10417000.0 in Q1 2026, 3013000.0 in Q4 2025, and 2944000.0 in Q3 2025.